Lv1
66 积分 2021-06-09 加入
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
5天前
已完结
Biomarker Correlates of Clinical Outcomes from a Global phase 1b Study of JNJ-90014496, CD20/CD19 Bi-Specific Chimeric Antigen Receptor (CAR) T-cell Therapy for Patients with Large B-cell Lymphoma (LBCL)
14天前
已完结
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer
19天前
已完结
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
19天前
已完结
Cell-Type Enrichment Analysis of Bulk Transcriptomes Using xCell
1个月前
已完结
Biological and clinical roles of IL-18 in inflammatory diseases
1个月前
已完结
Dynamic transitioning between MAPK-driven and WNT-driven cell states drives intestinal cancer and shapes therapy response
2个月前
已完结
The arrival of digital twins and in silico trials in drug development
2个月前
已完结
The Clinical Significance of Serum Interleukin-36α Levels in Patients with Gout
2个月前
已完结
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
